Clinical Trials Directory

Trials / Completed

CompletedNCT05443945

Efficacy of ADW S-100 Ionized Water Nasal Spray in Decreasing Symptoms of Allergic Rhinitis

Efficacy of ADW S-100 Ionized Water Nasal Spray in Decreasing Symptoms of Allergic Rhinitis: Randomized, Double-blind, Placebo-controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
95 (actual)
Sponsor
P & B Group · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A nasal spray based on Advanced Water S-100 ionized water would clean the nasal cavities, reduce the viscosity of mucus and facilitate its elimination and decongestion of the nose and the prevention of the bridging of the allergen to the epithelial cells of the cavity nose at the origin of the onset of symptoms. Indeed, a water-based nasal spray ionized Advanced Water S-100 would modify the electrostatic environment of all the interactions ensuring this bridging. Negative ions (OH-) contained in water ionized Advanced Water S-100 competes with negative ions from acids negatively charged amino acids and also neutralize basic amino acids positively charged. The destabilization of all the links governing the process of epitope/IgE association would prevent the bridging of the FcɛRI receptors of the mast cell and thus the cascade of cellular responses that cause symptoms. The purpose of this study is to assess whether the use of ionized water nasal spray ADW S-100 allows to sufficiently reduce the intensity of the symptoms of allergic rhinitis and thus improve the quality of life of people with allergies.

Conditions

Interventions

TypeNameDescription
DEVICENasal Spray3 sprays in each nostril 3 times per day

Timeline

Start date
2022-08-30
Primary completion
2023-08-14
Completion
2023-08-14
First posted
2022-07-05
Last updated
2023-09-21

Locations

11 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05443945. Inclusion in this directory is not an endorsement.